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ABSTRACT 
 
Purpose: A 3D fat-navigator (3D FatNavs) based retrospective motion correction is an elegant 
approach to correct for motion as it requires no additional hardware and can be acquired during 
existing ‘dead-time’ within common 3D protocols. The purpose of this study was to clinically 
evaluate 3D FatNavs in the work-up of brain tumors. 
 
Materials and Methods: An MRI-based fat-excitation motion navigator incorporated into a 
standard MPRAGE sequence was acquired in 40 consecutive patients with (or with suspected) 
brain tumors, pre and post-Gadolinium injection. Each case was categorized into key anatomical 
landmarks, the temporal lobes, the infra-tentorial region, the basal ganglia, the bifurcations of the 
middle cerebral artery and the A2 segment of the anterior cerebral artery. First, the severity of 
motion in the non-corrected MPRAGE was assessed for each landmark, using a 5-point score 
from 0 (no artifacts) to 4 (non-diagnostic). Second, the improvement in image quality in each pair 
and for each landmark was assessed blindly using a 4-point score from 0 (identical) to 3 (strong 
correction). 
 
Results: The mean image improvement score throughout the datasets was 0.54. Uncorrected 
cases with light and no artifacts displayed scores of 0.50 and 0.13 respectively, while cases with 
moderate artifacts, severe artifacts and non-diagnostic image quality revealed a mean score of 
1.17, 2.25 and 1.38 respectively. 
 
Conclusion: Fat-navigator based retrospective motion correction significantly improved 
MPRAGE image quality in restless patients during MRI acquisition. There was no loss of image 
quality in patients with little or no motion, and improvements were consistent in patients who 
moved more.  
  
 
INTRODUCTION 
 
A large group of patients, such as patients with dementia, Alzheimer disease, essential 
tremor or dystonia, Parkinson disease, epilepsy, or confusion can have difficulties staying quiet 
during a magnetic resonance (MR) imaging scan. Patient motion during MR scans can reduce 
image quality, weakening the diagnostic value of the examination, leading to repeated imaging, 
and increasing overall scan time and costs [1]. 
To cope with this challenge, different motion correction techniques have been developed. 
Early approaches already included radio frequency (RF)-based tracking systems and prospective 
motion correction [2, 3]. Recent methods range from external optical tracking systems [4–7] to 
MR-based motion tracking using self-navigation [8], navigator echoes [9], and image-based 
motion tracking [10]. Prospective motion correction techniques, such as vNav [11], PROMO [12], 
PACE [10] and FatNav [13, 14], involving the acquisition of a navigator around the readout train 
to update the imaging coordinates were successfully employed in the experimental setting, often 
with healthy volunteers being asked to move on command [11, 12]. Yet to our knowledge, studies 
on the added value of motion-correction in the clinical setting are sparse [15–17]. Further, many 
motion correction strategies require additional hardware and can require additional scan-time for 
additional motion-navigator scans or to repeat the acquisition of motion-corrupted subsets of the 
main data. 
In this context, techniques which can be implemented into dead-time portions of imaging 
acquisition are better fitted for clinical practice since they allow motion correction without an 
additional time penalty. The 3D fat-based motion navigator (3D FatNavs) method [18] is one 
technique, collecting a low-resolution fat image in the dead-time portion of scans to perform 
retrospective motion correction, and has been demonstrated to correct with high accuracy and 
produce excellent ultrahigh resolution images at high field strength [19, 20]. Previous works 
already used the high acceleration factors actionable by fat-selective excitation, to prospectively 
  
 
correct their datasets using 2D [13] and 3D navigators [14], yet again in a research or phantom-
based setting. 
The purpose of this study was to retrospectively quantify the added value of motion 
correction based on a 3D fat-based motion navigator (3D FatNavs) in the clinical setting of routine 
brain MRI scans. 
 
MATERIALS AND METHODS 
1. Study description 
This retrospective study was approved by the institutional review board of the __BLINDED 
FOR REVIEW__. The standard MPRAGE of our tumor brain protocol was replaced with a 3D 
FatNav MPRAGE sequence, described in detail below, in 40 consecutive patients with either 
suspicion of brain tumor, follow-up of tumor recurrence, or immediate post-operative margin 
controls.  
 
2. Image acquisition 
All studies were performed at the clinical facilities of the __BLINDED FOR REVIEW__ using 
the same 3-T MR imaging device MAGNETOM Skyra 3T (Siemens Healthcare, Erlangen, 
Germany), fitted with a maximum of 48-channel receiver head coil array. All patients underwent 
the same imaging protocol, which comprised a native and a contrast-enhanced three-dimensional, 
T1-weighted, gradient-echo MPRAGE, diffusion and susceptibility-weighted imaging, a T2-
weighted spin echo sequence, a FLAIR sequence and a perfusion protocol. 
When there was no contraindication for intravenous Gadolinium chelate contrast injection, a 
3D MPRAGE post-Gadolinium sequence was acquired, with each patient imaged receiving 
gadoterate meglumine (Dotarem, Guerbet, Villepinte, France) at either fixed doses of 20 mL or 
  
 
weight-based doses of 0.02 mL/Kg. Single adjustments were made with regard to the clinical 
context. 
 
3. 3D FatNavs MPRAGE sequence 
Subsequent analysis was performed solely on the native and contrast-enhanced 3D FatNavs 
MPRAGE sequence. We integrated a fat-based motion-navigator (3D FatNavs) into our standard 
MPRAGE sequence [21], which had a nominal resolution of 1.00 x 1.00 x 1.00 mm (matrix size = 
256 x 256), a repetition time (TR) = 2300 ms, an echo time (TE) = 2.26 ms and an inversion time 
(TI) = 900 ms. The 3D FatNavs consisted of a 3D gradient-recalled echo (GRE) sequence with a 
three-pulse binomial excitation to selectively stimulate at the frequency of fat and was acquired 
into the dead-time portions occurring after the readout train of the 3D MPRAGE and before the 
next inversion pulse, requiring an overall increase in scan duration of 3.4 seconds for the parallel 
imaging calibration prescan. The FatNavs acquisition parameters were: 4 mm isotropic resolution, 
44 x 64 x 64 matrix size, TE = 2.19 ms, TR = 4.6 ms, bandwidth =1950 Hz/pixel, flip angle = 3° 
and ¾ partial Fourier (reconstructed with zero filling) in both phase-encoding directions. Parallel 
imaging acceleration was 4x4 (GRAPPA) resulting in a total of 442 ms for each individual 3D 
FatNav. 
 
4. 3D FatNavs MPRAGE post-processing 
Reconstructed 3D FatNavs were co-registered using the “realign” tool in SPM (Statistical 
Parametrical Mapping, version 8) and the resulting estimated motion used to perform retrospective 
motion-correction separately for the raw k-space data from each RF channel of the respective 
host sequence, accounting for rotations by using the 3D non-uniform fast Fourier transform 
algorithm implemented by Jeffrey Fessler’s reconstruction toolbox [22]. The motion parameters 
were converted into the coordinate space of the MPRAGE acquisition prior to applying the 
  
 
correction. No additional density compensation was applied to k-space (which might be expected 
to improve image quality in cases of large motion). 
 
Since the inserted 3D FatNavs were used post-hoc to correct for motion that occurred during 
the acquisition, each study contained one uncorrected dataset and one matching corrected 
dataset, resulting in a total of four datasets after native and contrast-enhanced imaging. 
 
5. Motion detection 
The intercalated navigator sequences of 3D FatNavs were used to derive the absolute 
rotational (in degrees) and translational (in mm) motion parameters for each patient, in both native 
and contrast-enhanced studies. Additionally, the average root-mean-square (RMS) rotation and 
translation was calculated, with RMS values being expressed in degrees for rotation and in mm 
for translation. Motion parameters were estimated in reference to the coordinate frame of the 
scanner (as the 3D FatNavs are acquired at isocenter). 
 
6. Anatomical regions of interest 
Native and contrast-enhanced studies were assessed using a total of 5 predefined anatomical 
regions (Fig. 1). In the native studies, three structures were considered: the basal ganglia in the 
axial plane, the temporal lobes in the coronal plane, and the pons and the cerebellum in the sagittal 
plane. Post-contrast (when available), the A2-segments of the anterior cerebral artery in the 
sagittal plane and the M1-bifurcation of the middle cerebral artery in the axial plane were assessed 
additionally to the first three regions of interest. Combining native and contrast-enhanced datasets, 
8 regions of interests were assessed in total. 
 
7. Assessment of image quality and motion correction 
  
 
Each pair of uncorrected and corrected datasets was randomized by one of the co-authors 
(C.F.). Images were reviewed blindly by two readers, one general radiologist in residency training 
(C.G.) and one board-certified neuroradiology fellow (N.H.). The reading software used for this 
evaluation was 3DSlicer [23]. 
In a first step, the readers graded each the presence of motion artifacts in the 8 regions of all 
non-corrected studies using a 5-point motion artifacts (MA) score (0 = no artifacts; 1 = light 
artifacts; 2 = moderate artifacts; 3 = severe artifacts; 4 = non-diagnostic) and an ensuing 
consensus reading was performed, resulting in one MA score for each study. 
Second, at least two weeks after from the first step, the readers blindly evaluated whether one 
of the image stacks (corrected versus non-corrected) was of better quality and if yes, designated 
the images with the highest quality. Further, the scale of the improvement for each of the 8 regions 
was assessed using a 4-point score for image quality improvement following motion correction 
(IQIMC, 0 = no difference, 1 = light correction; 2 = moderate correction; 3 = strong correction).  
Both readers’ scores were subsequently averaged into one unique IQIMC score for each of the 
8 regions in each case. 
 
8.  Statistical analysis 
The IQIMC score was calculated for the total population and within the different MA subgroups. 
The Bland-Altman methodology was used to evaluate the inter-rater reliability for the assessment 
of both MA and IQIMC scores [24]. Cohen’s Kappa (k) was calculated to assess the inter-rater 
reliability in designating the image stacks with the better image quality between corrected and 
non-corrected [25]. Pearson's correlation coefficient was used to evaluate the 
linear correlation between the various variables. Paired, two-tailed Student t-tests were used to 
test for statistical significance. The significance level in this study was set to a = 0.05 
 
  
 
RESULTS 
1. Demographics 
40 patients were included in our study (25 men and 15 women [mean age, 59 years; range, 
27-86 years]), with a total of 77 datasets acquired (3 patients did not qualify for contrast-enhanced 
imaging), yielding a total of 305 anatomical regions to be evaluated for image quality improvement. 
The mean injected volume of gadoterate meglumine was 17 ± 3.5 mL [range 10-20 mL]. 
 
2. Image quality and quantitative motion detection 
118 regions presented with no motion artifacts (38.7%), 117 with light artifacts (38.4%), 44 
with moderate artifacts (14.4%), 6 with severe artifacts (1.97%) and 20 had a non-diagnostic value 
(6.56%). Nearly all sample values of the Bland-Altman plot for the inter-rater reliability in assessing 
MA scores were contained within the limits of agreement, with a mean bias of -0.04 between the 
two readers, Fig.2. 
The average RMS rotation and translation values during the scan for the native and contrast-
enhanced datasets were of 0.54° and 0.52 mm and 0.33° and 0.40 mm, respectively. Contrast-
enhanced datasets displayed significantly lower average RMS rotation and translation values 
(p<0.001). 
The average RMS rotation and translation values showed a positive, significant correlation 
with the MA scores achieved, 0.31 and 0.50 respectively (p<0.001), Fig.3. 
  
3. Image quality improvement after motion correction 
The overall average IQIMC score was 0.54 ± 0.06. With regard to MA subgroups, IQIMC 
scores were 0.13 ± 0.36 for the regions without artifacts, 0.50 ± 0.59 for the regions with light 
artifacts, 1.17 ± 0.64 for the regions with moderate artifacts, 2.25 ± 0.61 for the regions with severe 
  
 
artifacts and 1.38 ± 1.04 for the non-diagnostic regions. None (0/305) of the corrected anatomical 
regions was assessed as inferior in image quality by comparison with its non-corrected match. 
Inter-rater reliability for the blind designation of the image with highest quality was strong 
(κ=0.862, p < 0.001). Nearly all sample values of the Bland-Altman plot for the inter-rater reliability 
in assessing MC scores were contained within the limits of agreement, with a mean bias of -0.19 
between the two readers, Fig.2.  
Average RMS rotation and translation values, as well as the MA scores showed a positive, 
significant correlation with the IQIMC scores achieved, 0.55, 0.61 and 0.62 respectively (p<0.001), 
Fig.3. Examples of the typical image quality improvement obtained after utilization of 3D FatNavs 
are shown in Fig.4. 
  
  
 
DISCUSSION 
This study shows that 3D FatNavs with retrospective motion correction significantly improves 
image quality in patients with light to strong head motion during the scan, without altering the 
quality of images in patients with non-relevant motion, and with a negligible effect on overall scan 
time. Moderately and severely impaired regions displayed the highest motion correction values. 
Importantly, none of the of 305 anatomical regions evaluated showed image quality decrease after 
application of the retrospective correction. 
Very few studies report the use of motion correction techniques for head imaging in a clinical 
setting. Prospective motion correction in high-resolution 3D-T2-FLAIR acquisitions has been 
shown to be of interest [17] in epilepsy patients, however with several limitations, such as 
additional scan duration if the acquired stack was considered impaired. This study also lacked 
intraindividual assessment of motion correction between scans with and without the motion 
correction. Kochunov et al. [15] reported a retrospective motion correction technique using 
repetitive scanning and subsequent averaging of image stacks, with conclusive results but a 
requiring a significant increase of total scan duration. 
Compared to prospective motion correction techniques, retrospective motion correction 
method has in the clinical setting the advantage that non-corrected images are still acquired and 
available, which might increase the acceptance of the method in the workflow.  
 
In our study, the observed image improvement following motion correction significantly 
increased with the extent of the patients’ motion. This underlines the better performance of the 
correction tool given a more impaired dataset, while no or minimal motion could not be improved 
in a way to be subjectively noticeable.  
Interestingly, despite the correlation between the motion artifact scores and average RMS 
motion parameters, some patients with limited measured motion during the scan presented with 
  
 
larger-scaled motion artifacts. This might be due to the fact that cumulative effects of small 
rotations and translations might be responsible for larger motion artifacts.  
It is also possible that part of this motion was not detected by the navigator, and therefore 
could not be corrected. These cases do not account for a majority, however, since inter-scan 
motion represented the greater part of the overall head motion. As expected, even the 3D FatNavs 
motion correction could not produce high-quality images in the most severe cases of motion.  
Finally, given the posterior rotational center of the head, and the rigid body correction 
approach, the readers did not notice a higher occurrence of motion artifacts for the anterior areas, 
or for the infratentorial region. Average motion scores for the respective regions stayed within a 
similar, fit-to-comparison range, so that no further analyses were performed. Further, by breaking 
down our overall sample to each landmark, statistical power would have been compromised. 
 
The benefit of 3D FatNavs in terms of motion correction can certainly be extrapolated to 
other sequences than the MPRAGE, as well as other patient groups, although the technique is 
currently only employable for 3D sequences. For other acquisition schemes than MPRAGE, the 
scan time might be slightly increased, depending on the available dead-time within the particular 
sequence. 
 Certain limitations have to be acknowledged for this study. First, this was a single 
center retrospective study, without patient randomization or control for clinical factors. The number 
of patients was relatively small (nonetheless a larger cohort than most of the previous related 
studies). The average RMS motion parameters were not identical when compared intra-
individually, with significantly lower values for contrast-enhanced studies compared to pre-
contrast. We suspect that this results from the fact that patients were better accustomed to the 
MRI environment after one acquisition series, with gradual acclimation [26]. 
 
  
 
 In conclusion, this study shows that motion correction using 3D FatNavs successfully and 
reliably corrects for rigid head motion in the setting of clinical brain MRI studies, with negligible 
effect on total scan time. 
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Figures 
 
 
1. Planes and anatomical landmarks used for the assessment of artifacts and motion correction. A. Axial 
plane, view of the basal ganglia. B. Coronal plane, view of the temporal lobes. C. Sagittal plane, view of the 
infratentorial region. D. Sagittal plane, A2 segments of the anterior cerebral arteries. E. Axial plane, view of 
the M1 segment of the medial cerebral artery. 
  
  
 
 
2. Bland-Altman plots for the evaluation of the inter-rater reliability in assessing the Motion Artifacts scores 
(A) and the IQIMC scores (B). Only single values are situated outside the limits of agreements (small 
dotted lines) and most values are gathered around the mean score difference (bold dotted line). 
  
  
 
 
3. A. Box plot of the IQIMC scores in relation to the Motion Artifacts scores of the uncorrected datasets. 
The value of the correction is increasing with the severity of the motion, up to the worst images, in which a 
correction was not always possible. B-E. Scatter graphs of the IQIMC and MA scores in relation to the 
average RMS rotation and translation values. Note the increasing IQIMC scores as the body motion 
increases. MA scores display a partial correlation with the RMS motion values, probably due to the 
combination of rotation and translation in patients with high MA scores. 
  
  
 
 
4. A-B. Postoperative control after partial resection of a glioblastoma multiforme in a 48-year-old man. The 
patient presented with large, bulk motion during the scan, both translational (RMS 2.47mm) and rotational 
(RMS 3.10°).  The remaining tumor fronto-temporo-insular right (small white arrows), can be better 
delineated after motion correction. The left frontal operculum (long white arrow) particularly benefited from 
the motion correction. Although the images’ clearness and overall quality significantly improved after 
motion correction, residual motion artifacts nevertheless remained (white large arrowhead). C-D. Control 
in the course of a Temodal therapy in a 70 year old woman with known glioblastoma multiforme. Rigid 
body motion for this patient was limited, with smaller values of translational (RMS 0.51 mm) and rotational 
(RMS 0.43°) motion than the previous case. The M1 segment of the right medial cerebral artery displays 
sharper margins (long arrow), as well as the sulcus temporalis inferior on the right side (arrowhead). 
